Massive Interest for Asonor Anti-Snoring Solution at Expopharm '12 in Munich Germany

    HORSHOLM, DENMARK, November 11, 2012 /24-7PressRelease/ -- Asonor is a unique solution to avoid snoring and reducing the sound during the night. This will affect millions of people, i.e. approx. 50% of the population either because they are snoring themselves (app 40%) or because they are affected as a partner. Clinical studies and market experience document that 3 out of 4 will be able to improve significantly their quality of life and health situation by taking Asonor

EXPOPHARM is the natural choice for an international meeting place for manufacturers and distributors within the pharmaceutical industry. With this in mind Danish TannerMedico A/S, the manufacturer and owner of the intellectual properties of Asonor, again selected this event for meeting with its existing distributors and importantly to meet with potential new distributors in and outside Europe.

Asonor was shown at the Danish Pavilion together with products from 6 other Danish companies. With an excellent position in Hall B5 the Danish Pavilion and Asonor enjoyed a massive interest from interested customers and distributors.

Asonor scored highly at the biggest ever anti-snoring user test in Europe, according to reports from the Swedish organization Buzzador arranging this test performed by 1.000 men and woman with serious snoring problems. Impressive 66% did say that they find Asonor, anti-snoring solution better than other snoring products that they have used in the past.

TannerMedico manufacture and internationally distribute Asonor snore relief. Asonor is one of the world's leading products in snore treatment, studied and clinically proven in London and Copenhagen. Read also the latest news about sleep apnea and sleep disorders on www.asonor.com. For further information, please contact us at [email protected].

# # #